BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38610052)

  • 21. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.
    Pasmant E; Goussard P; Baranes L; Laurendeau I; Quentin S; Ponsot P; Consigny Y; Farges O; Condat B; Vidaud D; Vidaud M; Chen JM; Parfait B
    Eur J Hum Genet; 2012 Mar; 20(3):277-82. PubMed ID: 21989363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in
    Cheng J; Gong L; Mi X; Wu X; Zheng J; Yang W
    Front Med (Lausanne); 2022; 9():962408. PubMed ID: 36569137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
    Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
    J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.
    Lipiński P; Ciara E; Jurkiewicz D; Płoski R; Wawrzynowicz-Syczewska M; Pawłowska J; Jankowska I
    Ann Hepatol; 2021; 25():100342. PubMed ID: 33757843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
    Ziol M; Barbu V; Rosmorduc O; Frassati-Biaggi A; Barget N; Hermelin B; Scheffer GL; Bennouna S; Trinchet JC; Beaugrand M; Ganne-Carrié N
    Gastroenterology; 2008 Jul; 135(1):131-41. PubMed ID: 18482588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel heterozygous deletion in ABCB4 gene in a Chinese family with intrahepatic cholestasis of pregnancy, neonatal hyperbilirubinemia, and cholelithiasis: Case reports and literature review.
    Zheng Y; Rao Q; Han Y; He J
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2291. PubMed ID: 37787087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABCB4 disease mimicking morbus Wilson: A potential diagnostic pitfall.
    Sticova E; Neroldova M; Kotalova R; Subhanova I; Jirsa M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):121-125. PubMed ID: 31728073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
    Chen R; Yang FX; Tan YF; Deng M; Li H; Xu Y; Ouyang WX; Song YZ
    Orphanet J Rare Dis; 2022 Dec; 17(1):445. PubMed ID: 36550572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common ABCB4 and ABCB11 Genotypes Are Associated with Idiopathic Chronic Cholestasis in Adults.
    Jüngst C; Justinger C; Fischer J; Berg T; Lammert F
    Dig Dis; 2022; 40(4):489-496. PubMed ID: 34348275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3.
    Poupon R; Barbu V; Chamouard P; Wendum D; Rosmorduc O; Housset C
    Liver Int; 2010 Feb; 30(2):327-31. PubMed ID: 19840255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
    Degiorgio D; Colombo C; Seia M; Porcaro L; Costantino L; Zazzeron L; Bordo D; Coviello DA
    Eur J Hum Genet; 2007 Dec; 15(12):1230-8. PubMed ID: 17726488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
    Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
    Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
    Küçükçongar Yavaş A; Çavdarlı B; Ünal Uzun Ö; Uncuoğlu A; Gündüz M
    J Pediatr Endocrinol Metab; 2020 May; 33(5):665-669. PubMed ID: 32229667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of Cholestatic Liver Disease and Reduced Tumorigenicity in a Murine Model of PFIC Type 3 Using Hybrid AAV-piggyBac Gene Therapy.
    Siew SM; Cunningham SC; Zhu E; Tay SS; Venuti E; Bolitho C; Alexander IE
    Hepatology; 2019 Dec; 70(6):2047-2061. PubMed ID: 31099022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature.
    Delaunay JL; Durand-Schneider AM; Delautier D; Rada A; Gautherot J; Jacquemin E; Aït-Slimane T; Maurice M
    Hepatology; 2009 Apr; 49(4):1218-27. PubMed ID: 19185004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
    Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
    Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
    Moustafa T; Fickert P; Magnes C; Guelly C; Thueringer A; Frank S; Kratky D; Sattler W; Reicher H; Sinner F; Gumhold J; Silbert D; Fauler G; Höfler G; Lass A; Zechner R; Trauner M
    Gastroenterology; 2012 Jan; 142(1):140-151.e12. PubMed ID: 22001865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
    Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
    Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver diseases related to MDR3 (ABCB4) gene deficiency.
    Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
    Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.